Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 68, Issue 3, 2008, Pages 545-554

  Choi, Sung Hee ^a   Jin, Su Eon ^a   Lee, Mi Kyung ^b   Lim, Soo Jeong ^c   Park, Jeong Sook ^d   Kim, Byung Gyu ^e   Ahn, Woong Shick ^f   Kim, Chong Kook ^a  

^a Seoul National University   (South Korea)

^b Woosuk University   (South Korea)

^c Sejong University   (South Korea)

^d Chungnam National University   (South Korea)

^e NATIONAL CANCER INSTITUTE   (United States)

^f The Catholic University of Korea   (South Korea)

Author keywords

Cationic SLN; Lung cancer; Nonviral vector; p53

Indexed keywords

3BETA [N (N',N' DIMETHYLAMINOETHANE)CARBAMOYL]CHOLESTEROL; CATION; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; ENHANCED GREEN FLUORESCENT PROTEIN; LIPOCORTIN 5; LIPOFECTIN; MESSENGER RNA; PLASMID DNA; POLYSORBATE 80; PROTEIN P53; SOLID LIPID NANOPARTICLE; TRIDECANOIN; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CHEMICAL MODIFICATION; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG FORMULATION; FLUORESCENCE ACTIVATED CELL SORTING; FREEZE DRYING; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HEAT SENSITIVITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE;

EID: 39849103426     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.07.011     Document Type: Article

References (38)

1. S.L. Parker T. Tong S. Bolden P.A. Wingo Cancer statistics CA Cancer J. Clin. 47 1997 5 27
2. P. Bonomi Review of selected randomized trials in small cell lung cancer Semin. Oncol. 25 1998 70 78
3. B.E. Johnson R.I. Linnoila J.P. Williams D.J. Venzon P. Okunieff G.B. Anderson G.E. Richardson Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years J. Clin. Oncol. 13 1995 101 111
4. D. Sidransky M. Hollstein Clinical implications of the p53 gene Annu. Rev. Med. 47 1996 285 301
5. T. Takahashi D. Carbone T. Takahashi M.M. Nau T. Hida I. Linnoila R. Ueda J.D. Minna Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions Cancer Res. 52 1992 2340 2343
6. J. Nemunaitis S.G. Swisher T. Timmons D. Connors M. Mack L. Doerksen D. Weill J. Wait D.D. Lawrence B.L. Kemp F. Fossella B.S. Glisson W.K. Hong F.R. Khuri J.M. Kurie J.J. Lee J.S. Lee D.M. Nguyen J.C. Nesbitt R. Perez-Soler K.M. Pisters J.B. Putnam W.R. Richli D.M. Shin G.L. Walsh J. Merritt J. Roth Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer J. Clin. Oncol. 18 2000 609 622
7. L. Xu K.F. Pirollo E.H. Chang Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy J. Control Release 74 2001 115 128
8. C.K. Kim E.J. Choi S.H. Choi J.S. Park K.H. Haider W.S. Ahn Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC Gynecol. Oncol. 90 2003 265 272
9. C.H. Lee Y.H. Ni C.C. Chen C.K. Chou F.H. Chang Synergistic effect of polyethylenimine and cationic liposomes in nucleic acid delivery to human cancer cells Biochim. Biophys. Acta 1611 2003 55 62
10. F. Liu L. Huang Electric gene transfer to the liver following systemic administration of plasmid DNA Gene Ther. 9 2002 1116 1119
11. S.H. Gohla A. Dingler Scaling up feasibility of the production of solid lipid nanoparticles (SLN) Pharmazie 56 2001 61 63
12. K. Tabatt M. Sameti C. Olbrich R.H. Muller C.M. Lehr Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer Eur. J. Pharm. Biopharm. 57 2004 155 162
13. K. Tabatt C. Kneuer M. Sameti C. Olbrich R.H. Muller C.M. Lehr U. Bakowsky Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes J. Control Release 97 2004 321 332
14. C. Rudolph U. Schillinger A. Ortiz K. Tabatt C. Plank R.H. Muller J. Rosenecker Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo Pharm. Res. 21 2004 1662 1669
15. N. Pedersen S. Hansen A.V. Heydenreich H.G. Kristensen H.S. Poulsen Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands Eur. J. Pharm. Biopharm. 62 2006 155 162
16. C. Freitas R.H. Muller Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase Eur. J. Pharm. Biopharm. 47 1999 125 132
17. S.J. Lim C.K. Kim Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all- trans retinoic acid Int. J. Pharm. 243 2002 135 146
18. M. Joshi A. Misra Dry powder inhalation of liposomal Ketotifen fumarate: formulation and characterization Int. J. Pharm. 223 2001 15 27
19. K.S. Markley Fatty Acids 1983 Krieger New York
20. K. Westesen H. Bunjes Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix Int. J. Pharm. 115 1995 129 131
21. M.K. Lee S.J. Lim C.K. Kim Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles Biomaterials 28 2007 2137 2146
22. W.P. Bennett T.V. Colby W.D. Travis A. Borkowski R.T. Jones D.P. Lane R.A. Metcalf J.M. Samet Y. Takeshima J.R. Gu p53 protein accumulates frequently in early bronchial neoplasia Cancer Res. 53 1993 4817 4822
23. J.A. Roth D. Nguyen D.D. Lawrence B.L. Kemp C.H. Carrasco D.Z. Ferson W.K. Hong R. Komaki J.J. Lee J.C. Nesbitt K.M. Pisters J.B. Putnam R. Schea D.M. Shin G.L. Walsh M.M. Dolormente C.I. Han F.D. Martin N. Yen K. Xu L.C. Stephens T.J. McDonnell T. Mukhopadhyay D. Cai Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer Nat. Med. 2 1996 985 991
24. J.L. Coll A. Negoescu N. Louis L. Sachs C. Tenaud V. Girardot B. Demeinex E. Brambilla C. Brambilla M. Favrot Antitumor activity of bax and p53 naked gene transfer in lung cancer: in vitro and in vivo analysis Hum. Gene Ther. 9 1998 2063 2074
25. Y. Zou G. Zong Y.H. Ling M.M. Hao G. Lozano W.K. Hong R. Perez-Soler Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes J. Natl. Cancer Inst. 90 1998 1130 1137
26. C. Olbrich U. Bakowsky C.M. Lehr R.H. Müller C. Kneuer Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA J. Control Release 77 2001 345 355
27. W. Mehnert K. Mader Solid lipid nanoparticles: production, characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196
28. R.H. Muller A. Dingler T. Schneppe S. Gohla D. Wise Handbook of Pharmaceutical Controlled Release Technology 2000 Marcel Dekker New York 359 375
29. C. Schwarz W. Mehnert Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN) Int. J. Pharm. 157 1997 171 179
30. W.J. Choi J.K. Kim S.H. Choi J.S. Park W.S. Ahn C.K. Kim Low toxicity of cationic lipid-based emulsion for gene transfer Biomaterials 25 2004 5893 5903
31. E.H. Lee A. Kim Y.K. Oh C.K. Kim Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes Biomaterials 26 2005 205 210
32. M.K. Lee S.K. Chun W.J. Choi J.K. Kim S.H. Choi A. Kim K. Oungbho J.S. Park W.S. Ahn C.K. Kim The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer Biomaterials 26 2005 2147 2156
33. G. Nchinda K. Uberla O. Zschornig Characterization of cationic lipid DNA transfection complexes differing in susceptability to serum inhibition BMC Biotechnol. 2 2002 12 21
34. Recombinant DNA Advisory Committee (RAC) Committee Report: Human Gene Therapy Protocols, 1998.
35. K.M. Hege D.P. Carbone Lung cancer vaccines and gene therapy Lung Cancer 41 2003 S103 S113
36. C. Moon Y. Oh J.A. Roth Current status of gene therapy for lung cancer and head and neck cancer Clin. Cancer Res. 9 2003 5055 5067
37. S. Dow R. Elmslie I. Kurzman G. Macewen F. Pericle D. Liggitt Phase I study of liposome–DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases Hum. Gene Ther. 16 2005 937 946
38. I. Ito L. Ji F. Tanaka Y. Saito B. Gopalan C.D. Branch K. Xu E.N. Atkinson B.N. Bekele L.C. Stephens J.D. Minna J.A. Roth R. Ramesh Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo Cancer Gene Ther. 11 2004 733 739